Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? [Yahoo! Finance]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
its expectation that sales of its lead respiratory treatment, PAPZIMEOS, will exceed $18 million in the first quarter. It would be a significant increase, considering total sales for the candidate drug totaled $3.4 million in the fourth quarter of 2025. Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? David Smart/Shutterstock.com The significant sales increase would be driven by higher uptake, with patient hub enrollment having surpassed 300 patients in the fourth quarter. The US launch of the candidate drug continues to build strong momentum with a significant increase in the first quarter. In addition, Precigen has received a significant boost from the Centers for Medicare & Medicaid Services, which assigned a permanent J-code J3404, to PAPZIMEOS. The designation is poised to streamline the claims process and facilitate broader patient access. In addition, the company has already filed a Marketing Authorization Application for the use of the treatment on adult
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects [Yahoo! Finance]Yahoo! Finance
- Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point [Seeking Alpha]Seeking Alpha
- Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript [Seeking Alpha]Seeking Alpha
- Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat [Yahoo! Finance]Yahoo! Finance
- Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31PR Newswire
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form SCHEDULE
- 3/30/26 - Form 144
- PGEN's page on the SEC website